James L. Tyree - 09 Jun 2022 Form 4 Insider Report for ChemoCentryx, Inc.

Role
Director
Signature
/s/ Susan M. Kanaya, as Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
09 Jun 2022
Net transactions value
-$99,129
Form type
4
Filing time
13 Jun 2022, 18:28:00 UTC
Previous filing
31 May 2022
Next filing
08 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CCXI Common Stock Sale $97,582 -3,804 -17% $25.65 19,197 09 Jun 2022 Direct F1, F2
transaction CCXI Common Stock Sale $1,547 -59 -0.31% $26.22 19,138 09 Jun 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F2 Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $25.15 to $26.13 per share. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.